Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Landscape and Selection of Vaccine Epitopes in SARS-CoV-2.
Smith CC, Entwistle S, Willis C, Vensko S, Beck W, Garness J, Sambade M, Routh E, Olsen K, Kodysh J, O'Donnell T, Haber C, Heiss K, Stadler V, Garrison E, Grant OC, Woods RJ, Heise M, Vincent BG, Rubinsteyn A. Smith CC, et al. bioRxiv [Preprint]. 2020 Jun 4:2020.06.04.135004. doi: 10.1101/2020.06.04.135004. bioRxiv. 2020. Update in: Genome Med. 2021 Jun 14;13(1):101. doi: 10.1186/s13073-021-00910-1 PMID: 32577654 Free PMC article. Updated. Preprint.
Landscape and selection of vaccine epitopes in SARS-CoV-2.
Smith CC, Olsen KS, Gentry KM, Sambade M, Beck W, Garness J, Entwistle S, Willis C, Vensko S, Woods A, Fini M, Carpenter B, Routh E, Kodysh J, O'Donnell T, Haber C, Heiss K, Stadler V, Garrison E, Sandor AM, Ting JPY, Weiss J, Krajewski K, Grant OC, Woods RJ, Heise M, Vincent BG, Rubinsteyn A. Smith CC, et al. Genome Med. 2021 Jun 14;13(1):101. doi: 10.1186/s13073-021-00910-1. Genome Med. 2021. PMID: 34127050 Free PMC article.
Bulk and Single-Cell Profiling of Breast Tumors Identifies TREM-1 as a Dominant Immune Suppressive Marker Associated With Poor Outcomes.
Pullikuth AK, Routh ED, Zimmerman KD, Chifman J, Chou JW, Soike MH, Jin G, Su J, Song Q, Black MA, Print C, Bedognetti D, Howard-McNatt M, O'Neill SS, Thomas A, Langefeld CD, Sigalov AB, Lu Y, Miller LD. Pullikuth AK, et al. Among authors: routh ed. Front Oncol. 2021 Dec 8;11:734959. doi: 10.3389/fonc.2021.734959. eCollection 2021. Front Oncol. 2021. PMID: 34956864 Free PMC article.
Tumor mutational burden is a determinant of immune-mediated survival in breast cancer.
Thomas A, Routh ED, Pullikuth A, Jin G, Su J, Chou JW, Hoadley KA, Print C, Knowlton N, Black MA, Demaria S, Wang E, Bedognetti D, Jones WD, Mehta GA, Gatza ML, Perou CM, Page DB, Triozzi P, Miller LD. Thomas A, et al. Among authors: routh ed. Oncoimmunology. 2018 Jul 30;7(10):e1490854. doi: 10.1080/2162402X.2018.1490854. eCollection 2018. Oncoimmunology. 2018. PMID: 30386679 Free PMC article.
G-Quadruplex Helicase DHX36/G4R1 Engages Nuclear Lamina Proteins in Quiescent Breast Cancer Cells.
Richardson AE, Zentz ZA, Chambers AE, Sandwith SN, Reisinger MA, Saunders DW, Tompkins JD, Riggs AD, Routh ED, Rubenstein EM, Smaldino MA, Vaughn JP, Haney RA, Smaldino PJ. Richardson AE, et al. Among authors: routh ed. ACS Omega. 2020 Sep 16;5(38):24916-24926. doi: 10.1021/acsomega.0c03723. eCollection 2020 Sep 29. ACS Omega. 2020. PMID: 33015511 Free PMC article.
18 results